Global AI-driven Drug Discovery Supply, Demand and Key Producers, 2023-2029
AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials.
This report studies the global AI-driven Drug Discovery demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI-driven Drug Discovery, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI-driven Drug Discovery that contribute to its increasing demand across many markets.
The global AI-driven Drug Discovery market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Highlights and key features of the study
Global AI-driven Drug Discovery total market, 2018-2029, (USD Million)
Global AI-driven Drug Discovery total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: AI-driven Drug Discovery total market, key domestic companies and share, (USD Million)
Global AI-driven Drug Discovery revenue by player and market share 2018-2023, (USD Million)
Global AI-driven Drug Discovery total market by Type, CAGR, 2018-2029, (USD Million)
Global AI-driven Drug Discovery total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global AI-driven Drug Discovery market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Entos, Selvita, Benevolent, Exscientia, Euretos, Illumina with AstraZeneca, Novo Nordisk with Microsoft, Iktos and Aqemia, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AI-driven Drug Discovery market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global AI-driven Drug Discovery Market, By Region:
1. How big is the global AI-driven Drug Discovery market?
2. What is the demand of the global AI-driven Drug Discovery market?
3. What is the year over year growth of the global AI-driven Drug Discovery market?
4. What is the total value of the global AI-driven Drug Discovery market?
5. Who are the major players in the global AI-driven Drug Discovery market?
6. What are the growth factors driving the market demand?
This report studies the global AI-driven Drug Discovery demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI-driven Drug Discovery, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI-driven Drug Discovery that contribute to its increasing demand across many markets.
The global AI-driven Drug Discovery market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Highlights and key features of the study
Global AI-driven Drug Discovery total market, 2018-2029, (USD Million)
Global AI-driven Drug Discovery total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: AI-driven Drug Discovery total market, key domestic companies and share, (USD Million)
Global AI-driven Drug Discovery revenue by player and market share 2018-2023, (USD Million)
Global AI-driven Drug Discovery total market by Type, CAGR, 2018-2029, (USD Million)
Global AI-driven Drug Discovery total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global AI-driven Drug Discovery market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Entos, Selvita, Benevolent, Exscientia, Euretos, Illumina with AstraZeneca, Novo Nordisk with Microsoft, Iktos and Aqemia, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AI-driven Drug Discovery market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global AI-driven Drug Discovery Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Small Molecule Drug
- Biological Modeling
- Structural Biology
- Others
- Pharmaceutical and Biotechnology Companies
- Research Laboratories
- Entos
- Selvita
- Benevolent
- Exscientia
- Euretos
- Illumina with AstraZeneca
- Novo Nordisk with Microsoft
- Iktos
- Aqemia
- Zephyr AI
- Cyclicarx
- Eli Lilly
- Terray Therapeutics
- Ardigen
- ReviveMed
- Insilico Medicine
- XtalPi
- MindRank
- DP Technology
1. How big is the global AI-driven Drug Discovery market?
2. What is the demand of the global AI-driven Drug Discovery market?
3. What is the year over year growth of the global AI-driven Drug Discovery market?
4. What is the total value of the global AI-driven Drug Discovery market?
5. Who are the major players in the global AI-driven Drug Discovery market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 AI-driven Drug Discovery Introduction
1.2 World AI-driven Drug Discovery Market Size & Forecast (2018 & 2022 & 2029)
1.3 World AI-driven Drug Discovery Total Market by Region (by Headquarter Location)
1.3.1 World AI-driven Drug Discovery Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States AI-driven Drug Discovery Market Size (2018-2029)
1.3.3 China AI-driven Drug Discovery Market Size (2018-2029)
1.3.4 Europe AI-driven Drug Discovery Market Size (2018-2029)
1.3.5 Japan AI-driven Drug Discovery Market Size (2018-2029)
1.3.6 South Korea AI-driven Drug Discovery Market Size (2018-2029)
1.3.7 ASEAN AI-driven Drug Discovery Market Size (2018-2029)
1.3.8 India AI-driven Drug Discovery Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI-driven Drug Discovery Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 AI-driven Drug Discovery Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World AI-driven Drug Discovery Consumption Value (2018-2029)
2.2 World AI-driven Drug Discovery Consumption Value by Region
2.2.1 World AI-driven Drug Discovery Consumption Value by Region (2018-2023)
2.2.2 World AI-driven Drug Discovery Consumption Value Forecast by Region (2024-2029)
2.3 United States AI-driven Drug Discovery Consumption Value (2018-2029)
2.4 China AI-driven Drug Discovery Consumption Value (2018-2029)
2.5 Europe AI-driven Drug Discovery Consumption Value (2018-2029)
2.6 Japan AI-driven Drug Discovery Consumption Value (2018-2029)
2.7 South Korea AI-driven Drug Discovery Consumption Value (2018-2029)
2.8 ASEAN AI-driven Drug Discovery Consumption Value (2018-2029)
2.9 India AI-driven Drug Discovery Consumption Value (2018-2029)
3 WORLD AI-DRIVEN DRUG DISCOVERY COMPANIES COMPETITIVE ANALYSIS
3.1 World AI-driven Drug Discovery Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI-driven Drug Discovery Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI-driven Drug Discovery in 2022
3.2.3 Global Concentration Ratios (CR8) for AI-driven Drug Discovery in 2022
3.3 AI-driven Drug Discovery Company Evaluation Quadrant
3.4 AI-driven Drug Discovery Market: Overall Company Footprint Analysis
3.4.1 AI-driven Drug Discovery Market: Region Footprint
3.4.2 AI-driven Drug Discovery Market: Company Product Type Footprint
3.4.3 AI-driven Drug Discovery Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI-driven Drug Discovery Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI-driven Drug Discovery Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: AI-driven Drug Discovery Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: AI-driven Drug Discovery Consumption Value Comparison
4.2.1 United States VS China: AI-driven Drug Discovery Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: AI-driven Drug Discovery Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based AI-driven Drug Discovery Companies and Market Share, 2018-2023
4.3.1 United States Based AI-driven Drug Discovery Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI-driven Drug Discovery Revenue, (2018-2023)
4.4 China Based Companies AI-driven Drug Discovery Revenue and Market Share, 2018-2023
4.4.1 China Based AI-driven Drug Discovery Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI-driven Drug Discovery Revenue, (2018-2023)
4.5 Rest of World Based AI-driven Drug Discovery Companies and Market Share, 2018-2023
4.5.1 Rest of World Based AI-driven Drug Discovery Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies AI-driven Drug Discovery Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World AI-driven Drug Discovery Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Small Molecule Drug
5.2.2 Biological Modeling
5.2.3 Structural Biology
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World AI-driven Drug Discovery Market Size by Type (2018-2023)
5.3.2 World AI-driven Drug Discovery Market Size by Type (2024-2029)
5.3.3 World AI-driven Drug Discovery Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World AI-driven Drug Discovery Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical and Biotechnology Companies
6.2.2 Research Laboratories
6.3 Market Segment by Application
6.3.1 World AI-driven Drug Discovery Market Size by Application (2018-2023)
6.3.2 World AI-driven Drug Discovery Market Size by Application (2024-2029)
6.3.3 World AI-driven Drug Discovery Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Entos
7.1.1 Entos Details
7.1.2 Entos Major Business
7.1.3 Entos AI-driven Drug Discovery Product and Services
7.1.4 Entos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Entos Recent Developments/Updates
7.1.6 Entos Competitive Strengths & Weaknesses
7.2 Selvita
7.2.1 Selvita Details
7.2.2 Selvita Major Business
7.2.3 Selvita AI-driven Drug Discovery Product and Services
7.2.4 Selvita AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Selvita Recent Developments/Updates
7.2.6 Selvita Competitive Strengths & Weaknesses
7.3 Benevolent
7.3.1 Benevolent Details
7.3.2 Benevolent Major Business
7.3.3 Benevolent AI-driven Drug Discovery Product and Services
7.3.4 Benevolent AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Benevolent Recent Developments/Updates
7.3.6 Benevolent Competitive Strengths & Weaknesses
7.4 Exscientia
7.4.1 Exscientia Details
7.4.2 Exscientia Major Business
7.4.3 Exscientia AI-driven Drug Discovery Product and Services
7.4.4 Exscientia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Exscientia Recent Developments/Updates
7.4.6 Exscientia Competitive Strengths & Weaknesses
7.5 Euretos
7.5.1 Euretos Details
7.5.2 Euretos Major Business
7.5.3 Euretos AI-driven Drug Discovery Product and Services
7.5.4 Euretos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Euretos Recent Developments/Updates
7.5.6 Euretos Competitive Strengths & Weaknesses
7.6 Illumina with AstraZeneca
7.6.1 Illumina with AstraZeneca Details
7.6.2 Illumina with AstraZeneca Major Business
7.6.3 Illumina with AstraZeneca AI-driven Drug Discovery Product and Services
7.6.4 Illumina with AstraZeneca AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Illumina with AstraZeneca Recent Developments/Updates
7.6.6 Illumina with AstraZeneca Competitive Strengths & Weaknesses
7.7 Novo Nordisk with Microsoft
7.7.1 Novo Nordisk with Microsoft Details
7.7.2 Novo Nordisk with Microsoft Major Business
7.7.3 Novo Nordisk with Microsoft AI-driven Drug Discovery Product and Services
7.7.4 Novo Nordisk with Microsoft AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Novo Nordisk with Microsoft Recent Developments/Updates
7.7.6 Novo Nordisk with Microsoft Competitive Strengths & Weaknesses
7.8 Iktos
7.8.1 Iktos Details
7.8.2 Iktos Major Business
7.8.3 Iktos AI-driven Drug Discovery Product and Services
7.8.4 Iktos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Iktos Recent Developments/Updates
7.8.6 Iktos Competitive Strengths & Weaknesses
7.9 Aqemia
7.9.1 Aqemia Details
7.9.2 Aqemia Major Business
7.9.3 Aqemia AI-driven Drug Discovery Product and Services
7.9.4 Aqemia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Aqemia Recent Developments/Updates
7.9.6 Aqemia Competitive Strengths & Weaknesses
7.10 Zephyr AI
7.10.1 Zephyr AI Details
7.10.2 Zephyr AI Major Business
7.10.3 Zephyr AI AI-driven Drug Discovery Product and Services
7.10.4 Zephyr AI AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Zephyr AI Recent Developments/Updates
7.10.6 Zephyr AI Competitive Strengths & Weaknesses
7.11 Cyclicarx
7.11.1 Cyclicarx Details
7.11.2 Cyclicarx Major Business
7.11.3 Cyclicarx AI-driven Drug Discovery Product and Services
7.11.4 Cyclicarx AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Cyclicarx Recent Developments/Updates
7.11.6 Cyclicarx Competitive Strengths & Weaknesses
7.12 Eli Lilly
7.12.1 Eli Lilly Details
7.12.2 Eli Lilly Major Business
7.12.3 Eli Lilly AI-driven Drug Discovery Product and Services
7.12.4 Eli Lilly AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Eli Lilly Recent Developments/Updates
7.12.6 Eli Lilly Competitive Strengths & Weaknesses
7.13 Terray Therapeutics
7.13.1 Terray Therapeutics Details
7.13.2 Terray Therapeutics Major Business
7.13.3 Terray Therapeutics AI-driven Drug Discovery Product and Services
7.13.4 Terray Therapeutics AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Terray Therapeutics Recent Developments/Updates
7.13.6 Terray Therapeutics Competitive Strengths & Weaknesses
7.14 Ardigen
7.14.1 Ardigen Details
7.14.2 Ardigen Major Business
7.14.3 Ardigen AI-driven Drug Discovery Product and Services
7.14.4 Ardigen AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Ardigen Recent Developments/Updates
7.14.6 Ardigen Competitive Strengths & Weaknesses
7.15 ReviveMed
7.15.1 ReviveMed Details
7.15.2 ReviveMed Major Business
7.15.3 ReviveMed AI-driven Drug Discovery Product and Services
7.15.4 ReviveMed AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 ReviveMed Recent Developments/Updates
7.15.6 ReviveMed Competitive Strengths & Weaknesses
7.16 Insilico Medicine
7.16.1 Insilico Medicine Details
7.16.2 Insilico Medicine Major Business
7.16.3 Insilico Medicine AI-driven Drug Discovery Product and Services
7.16.4 Insilico Medicine AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Insilico Medicine Recent Developments/Updates
7.16.6 Insilico Medicine Competitive Strengths & Weaknesses
7.17 XtalPi
7.17.1 XtalPi Details
7.17.2 XtalPi Major Business
7.17.3 XtalPi AI-driven Drug Discovery Product and Services
7.17.4 XtalPi AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 XtalPi Recent Developments/Updates
7.17.6 XtalPi Competitive Strengths & Weaknesses
7.18 MindRank
7.18.1 MindRank Details
7.18.2 MindRank Major Business
7.18.3 MindRank AI-driven Drug Discovery Product and Services
7.18.4 MindRank AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 MindRank Recent Developments/Updates
7.18.6 MindRank Competitive Strengths & Weaknesses
7.19 DP Technology
7.19.1 DP Technology Details
7.19.2 DP Technology Major Business
7.19.3 DP Technology AI-driven Drug Discovery Product and Services
7.19.4 DP Technology AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 DP Technology Recent Developments/Updates
7.19.6 DP Technology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 AI-driven Drug Discovery Industry Chain
8.2 AI-driven Drug Discovery Upstream Analysis
8.3 AI-driven Drug Discovery Midstream Analysis
8.4 AI-driven Drug Discovery Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 AI-driven Drug Discovery Introduction
1.2 World AI-driven Drug Discovery Market Size & Forecast (2018 & 2022 & 2029)
1.3 World AI-driven Drug Discovery Total Market by Region (by Headquarter Location)
1.3.1 World AI-driven Drug Discovery Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States AI-driven Drug Discovery Market Size (2018-2029)
1.3.3 China AI-driven Drug Discovery Market Size (2018-2029)
1.3.4 Europe AI-driven Drug Discovery Market Size (2018-2029)
1.3.5 Japan AI-driven Drug Discovery Market Size (2018-2029)
1.3.6 South Korea AI-driven Drug Discovery Market Size (2018-2029)
1.3.7 ASEAN AI-driven Drug Discovery Market Size (2018-2029)
1.3.8 India AI-driven Drug Discovery Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI-driven Drug Discovery Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 AI-driven Drug Discovery Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World AI-driven Drug Discovery Consumption Value (2018-2029)
2.2 World AI-driven Drug Discovery Consumption Value by Region
2.2.1 World AI-driven Drug Discovery Consumption Value by Region (2018-2023)
2.2.2 World AI-driven Drug Discovery Consumption Value Forecast by Region (2024-2029)
2.3 United States AI-driven Drug Discovery Consumption Value (2018-2029)
2.4 China AI-driven Drug Discovery Consumption Value (2018-2029)
2.5 Europe AI-driven Drug Discovery Consumption Value (2018-2029)
2.6 Japan AI-driven Drug Discovery Consumption Value (2018-2029)
2.7 South Korea AI-driven Drug Discovery Consumption Value (2018-2029)
2.8 ASEAN AI-driven Drug Discovery Consumption Value (2018-2029)
2.9 India AI-driven Drug Discovery Consumption Value (2018-2029)
3 WORLD AI-DRIVEN DRUG DISCOVERY COMPANIES COMPETITIVE ANALYSIS
3.1 World AI-driven Drug Discovery Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI-driven Drug Discovery Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI-driven Drug Discovery in 2022
3.2.3 Global Concentration Ratios (CR8) for AI-driven Drug Discovery in 2022
3.3 AI-driven Drug Discovery Company Evaluation Quadrant
3.4 AI-driven Drug Discovery Market: Overall Company Footprint Analysis
3.4.1 AI-driven Drug Discovery Market: Region Footprint
3.4.2 AI-driven Drug Discovery Market: Company Product Type Footprint
3.4.3 AI-driven Drug Discovery Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI-driven Drug Discovery Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI-driven Drug Discovery Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: AI-driven Drug Discovery Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: AI-driven Drug Discovery Consumption Value Comparison
4.2.1 United States VS China: AI-driven Drug Discovery Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: AI-driven Drug Discovery Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based AI-driven Drug Discovery Companies and Market Share, 2018-2023
4.3.1 United States Based AI-driven Drug Discovery Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI-driven Drug Discovery Revenue, (2018-2023)
4.4 China Based Companies AI-driven Drug Discovery Revenue and Market Share, 2018-2023
4.4.1 China Based AI-driven Drug Discovery Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI-driven Drug Discovery Revenue, (2018-2023)
4.5 Rest of World Based AI-driven Drug Discovery Companies and Market Share, 2018-2023
4.5.1 Rest of World Based AI-driven Drug Discovery Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies AI-driven Drug Discovery Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World AI-driven Drug Discovery Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Small Molecule Drug
5.2.2 Biological Modeling
5.2.3 Structural Biology
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World AI-driven Drug Discovery Market Size by Type (2018-2023)
5.3.2 World AI-driven Drug Discovery Market Size by Type (2024-2029)
5.3.3 World AI-driven Drug Discovery Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World AI-driven Drug Discovery Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical and Biotechnology Companies
6.2.2 Research Laboratories
6.3 Market Segment by Application
6.3.1 World AI-driven Drug Discovery Market Size by Application (2018-2023)
6.3.2 World AI-driven Drug Discovery Market Size by Application (2024-2029)
6.3.3 World AI-driven Drug Discovery Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Entos
7.1.1 Entos Details
7.1.2 Entos Major Business
7.1.3 Entos AI-driven Drug Discovery Product and Services
7.1.4 Entos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Entos Recent Developments/Updates
7.1.6 Entos Competitive Strengths & Weaknesses
7.2 Selvita
7.2.1 Selvita Details
7.2.2 Selvita Major Business
7.2.3 Selvita AI-driven Drug Discovery Product and Services
7.2.4 Selvita AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Selvita Recent Developments/Updates
7.2.6 Selvita Competitive Strengths & Weaknesses
7.3 Benevolent
7.3.1 Benevolent Details
7.3.2 Benevolent Major Business
7.3.3 Benevolent AI-driven Drug Discovery Product and Services
7.3.4 Benevolent AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Benevolent Recent Developments/Updates
7.3.6 Benevolent Competitive Strengths & Weaknesses
7.4 Exscientia
7.4.1 Exscientia Details
7.4.2 Exscientia Major Business
7.4.3 Exscientia AI-driven Drug Discovery Product and Services
7.4.4 Exscientia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Exscientia Recent Developments/Updates
7.4.6 Exscientia Competitive Strengths & Weaknesses
7.5 Euretos
7.5.1 Euretos Details
7.5.2 Euretos Major Business
7.5.3 Euretos AI-driven Drug Discovery Product and Services
7.5.4 Euretos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Euretos Recent Developments/Updates
7.5.6 Euretos Competitive Strengths & Weaknesses
7.6 Illumina with AstraZeneca
7.6.1 Illumina with AstraZeneca Details
7.6.2 Illumina with AstraZeneca Major Business
7.6.3 Illumina with AstraZeneca AI-driven Drug Discovery Product and Services
7.6.4 Illumina with AstraZeneca AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Illumina with AstraZeneca Recent Developments/Updates
7.6.6 Illumina with AstraZeneca Competitive Strengths & Weaknesses
7.7 Novo Nordisk with Microsoft
7.7.1 Novo Nordisk with Microsoft Details
7.7.2 Novo Nordisk with Microsoft Major Business
7.7.3 Novo Nordisk with Microsoft AI-driven Drug Discovery Product and Services
7.7.4 Novo Nordisk with Microsoft AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Novo Nordisk with Microsoft Recent Developments/Updates
7.7.6 Novo Nordisk with Microsoft Competitive Strengths & Weaknesses
7.8 Iktos
7.8.1 Iktos Details
7.8.2 Iktos Major Business
7.8.3 Iktos AI-driven Drug Discovery Product and Services
7.8.4 Iktos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Iktos Recent Developments/Updates
7.8.6 Iktos Competitive Strengths & Weaknesses
7.9 Aqemia
7.9.1 Aqemia Details
7.9.2 Aqemia Major Business
7.9.3 Aqemia AI-driven Drug Discovery Product and Services
7.9.4 Aqemia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Aqemia Recent Developments/Updates
7.9.6 Aqemia Competitive Strengths & Weaknesses
7.10 Zephyr AI
7.10.1 Zephyr AI Details
7.10.2 Zephyr AI Major Business
7.10.3 Zephyr AI AI-driven Drug Discovery Product and Services
7.10.4 Zephyr AI AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Zephyr AI Recent Developments/Updates
7.10.6 Zephyr AI Competitive Strengths & Weaknesses
7.11 Cyclicarx
7.11.1 Cyclicarx Details
7.11.2 Cyclicarx Major Business
7.11.3 Cyclicarx AI-driven Drug Discovery Product and Services
7.11.4 Cyclicarx AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Cyclicarx Recent Developments/Updates
7.11.6 Cyclicarx Competitive Strengths & Weaknesses
7.12 Eli Lilly
7.12.1 Eli Lilly Details
7.12.2 Eli Lilly Major Business
7.12.3 Eli Lilly AI-driven Drug Discovery Product and Services
7.12.4 Eli Lilly AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Eli Lilly Recent Developments/Updates
7.12.6 Eli Lilly Competitive Strengths & Weaknesses
7.13 Terray Therapeutics
7.13.1 Terray Therapeutics Details
7.13.2 Terray Therapeutics Major Business
7.13.3 Terray Therapeutics AI-driven Drug Discovery Product and Services
7.13.4 Terray Therapeutics AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Terray Therapeutics Recent Developments/Updates
7.13.6 Terray Therapeutics Competitive Strengths & Weaknesses
7.14 Ardigen
7.14.1 Ardigen Details
7.14.2 Ardigen Major Business
7.14.3 Ardigen AI-driven Drug Discovery Product and Services
7.14.4 Ardigen AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Ardigen Recent Developments/Updates
7.14.6 Ardigen Competitive Strengths & Weaknesses
7.15 ReviveMed
7.15.1 ReviveMed Details
7.15.2 ReviveMed Major Business
7.15.3 ReviveMed AI-driven Drug Discovery Product and Services
7.15.4 ReviveMed AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 ReviveMed Recent Developments/Updates
7.15.6 ReviveMed Competitive Strengths & Weaknesses
7.16 Insilico Medicine
7.16.1 Insilico Medicine Details
7.16.2 Insilico Medicine Major Business
7.16.3 Insilico Medicine AI-driven Drug Discovery Product and Services
7.16.4 Insilico Medicine AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Insilico Medicine Recent Developments/Updates
7.16.6 Insilico Medicine Competitive Strengths & Weaknesses
7.17 XtalPi
7.17.1 XtalPi Details
7.17.2 XtalPi Major Business
7.17.3 XtalPi AI-driven Drug Discovery Product and Services
7.17.4 XtalPi AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 XtalPi Recent Developments/Updates
7.17.6 XtalPi Competitive Strengths & Weaknesses
7.18 MindRank
7.18.1 MindRank Details
7.18.2 MindRank Major Business
7.18.3 MindRank AI-driven Drug Discovery Product and Services
7.18.4 MindRank AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 MindRank Recent Developments/Updates
7.18.6 MindRank Competitive Strengths & Weaknesses
7.19 DP Technology
7.19.1 DP Technology Details
7.19.2 DP Technology Major Business
7.19.3 DP Technology AI-driven Drug Discovery Product and Services
7.19.4 DP Technology AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 DP Technology Recent Developments/Updates
7.19.6 DP Technology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 AI-driven Drug Discovery Industry Chain
8.2 AI-driven Drug Discovery Upstream Analysis
8.3 AI-driven Drug Discovery Midstream Analysis
8.4 AI-driven Drug Discovery Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World AI-driven Drug Discovery Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World AI-driven Drug Discovery Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World AI-driven Drug Discovery Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World AI-driven Drug Discovery Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World AI-driven Drug Discovery Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI-driven Drug Discovery Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World AI-driven Drug Discovery Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World AI-driven Drug Discovery Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World AI-driven Drug Discovery Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key AI-driven Drug Discovery Players in 2022
Table 12. World AI-driven Drug Discovery Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global AI-driven Drug Discovery Company Evaluation Quadrant
Table 14. Head Office of Key AI-driven Drug Discovery Player
Table 15. AI-driven Drug Discovery Market: Company Product Type Footprint
Table 16. AI-driven Drug Discovery Market: Company Product Application Footprint
Table 17. AI-driven Drug Discovery Mergers & Acquisitions Activity
Table 18. United States VS China AI-driven Drug Discovery Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China AI-driven Drug Discovery Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based AI-driven Drug Discovery Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI-driven Drug Discovery Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies AI-driven Drug Discovery Revenue Market Share (2018-2023)
Table 23. China Based AI-driven Drug Discovery Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI-driven Drug Discovery Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies AI-driven Drug Discovery Revenue Market Share (2018-2023)
Table 26. Rest of World Based AI-driven Drug Discovery Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies AI-driven Drug Discovery Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies AI-driven Drug Discovery Revenue Market Share (2018-2023)
Table 29. World AI-driven Drug Discovery Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World AI-driven Drug Discovery Market Size by Type (2018-2023) & (USD Million)
Table 31. World AI-driven Drug Discovery Market Size by Type (2024-2029) & (USD Million)
Table 32. World AI-driven Drug Discovery Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World AI-driven Drug Discovery Market Size by Application (2018-2023) & (USD Million)
Table 34. World AI-driven Drug Discovery Market Size by Application (2024-2029) & (USD Million)
Table 35. Entos Basic Information, Area Served and Competitors
Table 36. Entos Major Business
Table 37. Entos AI-driven Drug Discovery Product and Services
Table 38. Entos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Entos Recent Developments/Updates
Table 40. Entos Competitive Strengths & Weaknesses
Table 41. Selvita Basic Information, Area Served and Competitors
Table 42. Selvita Major Business
Table 43. Selvita AI-driven Drug Discovery Product and Services
Table 44. Selvita AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Selvita Recent Developments/Updates
Table 46. Selvita Competitive Strengths & Weaknesses
Table 47. Benevolent Basic Information, Area Served and Competitors
Table 48. Benevolent Major Business
Table 49. Benevolent AI-driven Drug Discovery Product and Services
Table 50. Benevolent AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Benevolent Recent Developments/Updates
Table 52. Benevolent Competitive Strengths & Weaknesses
Table 53. Exscientia Basic Information, Area Served and Competitors
Table 54. Exscientia Major Business
Table 55. Exscientia AI-driven Drug Discovery Product and Services
Table 56. Exscientia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Exscientia Recent Developments/Updates
Table 58. Exscientia Competitive Strengths & Weaknesses
Table 59. Euretos Basic Information, Area Served and Competitors
Table 60. Euretos Major Business
Table 61. Euretos AI-driven Drug Discovery Product and Services
Table 62. Euretos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Euretos Recent Developments/Updates
Table 64. Euretos Competitive Strengths & Weaknesses
Table 65. Illumina with AstraZeneca Basic Information, Area Served and Competitors
Table 66. Illumina with AstraZeneca Major Business
Table 67. Illumina with AstraZeneca AI-driven Drug Discovery Product and Services
Table 68. Illumina with AstraZeneca AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Illumina with AstraZeneca Recent Developments/Updates
Table 70. Illumina with AstraZeneca Competitive Strengths & Weaknesses
Table 71. Novo Nordisk with Microsoft Basic Information, Area Served and Competitors
Table 72. Novo Nordisk with Microsoft Major Business
Table 73. Novo Nordisk with Microsoft AI-driven Drug Discovery Product and Services
Table 74. Novo Nordisk with Microsoft AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Novo Nordisk with Microsoft Recent Developments/Updates
Table 76. Novo Nordisk with Microsoft Competitive Strengths & Weaknesses
Table 77. Iktos Basic Information, Area Served and Competitors
Table 78. Iktos Major Business
Table 79. Iktos AI-driven Drug Discovery Product and Services
Table 80. Iktos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Iktos Recent Developments/Updates
Table 82. Iktos Competitive Strengths & Weaknesses
Table 83. Aqemia Basic Information, Area Served and Competitors
Table 84. Aqemia Major Business
Table 85. Aqemia AI-driven Drug Discovery Product and Services
Table 86. Aqemia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Aqemia Recent Developments/Updates
Table 88. Aqemia Competitive Strengths & Weaknesses
Table 89. Zephyr AI Basic Information, Area Served and Competitors
Table 90. Zephyr AI Major Business
Table 91. Zephyr AI AI-driven Drug Discovery Product and Services
Table 92. Zephyr AI AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Zephyr AI Recent Developments/Updates
Table 94. Zephyr AI Competitive Strengths & Weaknesses
Table 95. Cyclicarx Basic Information, Area Served and Competitors
Table 96. Cyclicarx Major Business
Table 97. Cyclicarx AI-driven Drug Discovery Product and Services
Table 98. Cyclicarx AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Cyclicarx Recent Developments/Updates
Table 100. Cyclicarx Competitive Strengths & Weaknesses
Table 101. Eli Lilly Basic Information, Area Served and Competitors
Table 102. Eli Lilly Major Business
Table 103. Eli Lilly AI-driven Drug Discovery Product and Services
Table 104. Eli Lilly AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Eli Lilly Recent Developments/Updates
Table 106. Eli Lilly Competitive Strengths & Weaknesses
Table 107. Terray Therapeutics Basic Information, Area Served and Competitors
Table 108. Terray Therapeutics Major Business
Table 109. Terray Therapeutics AI-driven Drug Discovery Product and Services
Table 110. Terray Therapeutics AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Terray Therapeutics Recent Developments/Updates
Table 112. Terray Therapeutics Competitive Strengths & Weaknesses
Table 113. Ardigen Basic Information, Area Served and Competitors
Table 114. Ardigen Major Business
Table 115. Ardigen AI-driven Drug Discovery Product and Services
Table 116. Ardigen AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Ardigen Recent Developments/Updates
Table 118. Ardigen Competitive Strengths & Weaknesses
Table 119. ReviveMed Basic Information, Area Served and Competitors
Table 120. ReviveMed Major Business
Table 121. ReviveMed AI-driven Drug Discovery Product and Services
Table 122. ReviveMed AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. ReviveMed Recent Developments/Updates
Table 124. ReviveMed Competitive Strengths & Weaknesses
Table 125. Insilico Medicine Basic Information, Area Served and Competitors
Table 126. Insilico Medicine Major Business
Table 127. Insilico Medicine AI-driven Drug Discovery Product and Services
Table 128. Insilico Medicine AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Insilico Medicine Recent Developments/Updates
Table 130. Insilico Medicine Competitive Strengths & Weaknesses
Table 131. XtalPi Basic Information, Area Served and Competitors
Table 132. XtalPi Major Business
Table 133. XtalPi AI-driven Drug Discovery Product and Services
Table 134. XtalPi AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. XtalPi Recent Developments/Updates
Table 136. XtalPi Competitive Strengths & Weaknesses
Table 137. MindRank Basic Information, Area Served and Competitors
Table 138. MindRank Major Business
Table 139. MindRank AI-driven Drug Discovery Product and Services
Table 140. MindRank AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. MindRank Recent Developments/Updates
Table 142. DP Technology Basic Information, Area Served and Competitors
Table 143. DP Technology Major Business
Table 144. DP Technology AI-driven Drug Discovery Product and Services
Table 145. DP Technology AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 146. Global Key Players of AI-driven Drug Discovery Upstream (Raw Materials)
Table 147. AI-driven Drug Discovery Typical Customers
List of Figure
Figure 1. AI-driven Drug Discovery Picture
Figure 2. World AI-driven Drug Discovery Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World AI-driven Drug Discovery Total Market Size (2018-2029) & (USD Million)
Figure 4. World AI-driven Drug Discovery Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World AI-driven Drug Discovery Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company AI-driven Drug Discovery Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company AI-driven Drug Discovery Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company AI-driven Drug Discovery Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company AI-driven Drug Discovery Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company AI-driven Drug Discovery Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company AI-driven Drug Discovery Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company AI-driven Drug Discovery Revenue (2018-2029) & (USD Million)
Figure 13. AI-driven Drug Discovery Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 16. World AI-driven Drug Discovery Consumption Value Market Share by Region (2018-2029)
Figure 17. United States AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 18. China AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 23. India AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of AI-driven Drug Discovery by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI-driven Drug Discovery Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI-driven Drug Discovery Markets in 2022
Figure 27. United States VS China: AI-driven Drug Discovery Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: AI-driven Drug Discovery Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World AI-driven Drug Discovery Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World AI-driven Drug Discovery Market Size Market Share by Type in 2022
Figure 31. Small Molecule Drug
Figure 32. Biological Modeling
Figure 33. Structural Biology
Figure 34. Others
Figure 35. World AI-driven Drug Discovery Market Size Market Share by Type (2018-2029)
Figure 36. World AI-driven Drug Discovery Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World AI-driven Drug Discovery Market Size Market Share by Application in 2022
Figure 38. Pharmaceutical and Biotechnology Companies
Figure 39. Research Laboratories
Figure 40. AI-driven Drug Discovery Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Table 1. World AI-driven Drug Discovery Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World AI-driven Drug Discovery Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World AI-driven Drug Discovery Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World AI-driven Drug Discovery Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World AI-driven Drug Discovery Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI-driven Drug Discovery Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World AI-driven Drug Discovery Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World AI-driven Drug Discovery Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World AI-driven Drug Discovery Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key AI-driven Drug Discovery Players in 2022
Table 12. World AI-driven Drug Discovery Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global AI-driven Drug Discovery Company Evaluation Quadrant
Table 14. Head Office of Key AI-driven Drug Discovery Player
Table 15. AI-driven Drug Discovery Market: Company Product Type Footprint
Table 16. AI-driven Drug Discovery Market: Company Product Application Footprint
Table 17. AI-driven Drug Discovery Mergers & Acquisitions Activity
Table 18. United States VS China AI-driven Drug Discovery Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China AI-driven Drug Discovery Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based AI-driven Drug Discovery Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI-driven Drug Discovery Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies AI-driven Drug Discovery Revenue Market Share (2018-2023)
Table 23. China Based AI-driven Drug Discovery Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI-driven Drug Discovery Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies AI-driven Drug Discovery Revenue Market Share (2018-2023)
Table 26. Rest of World Based AI-driven Drug Discovery Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies AI-driven Drug Discovery Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies AI-driven Drug Discovery Revenue Market Share (2018-2023)
Table 29. World AI-driven Drug Discovery Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World AI-driven Drug Discovery Market Size by Type (2018-2023) & (USD Million)
Table 31. World AI-driven Drug Discovery Market Size by Type (2024-2029) & (USD Million)
Table 32. World AI-driven Drug Discovery Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World AI-driven Drug Discovery Market Size by Application (2018-2023) & (USD Million)
Table 34. World AI-driven Drug Discovery Market Size by Application (2024-2029) & (USD Million)
Table 35. Entos Basic Information, Area Served and Competitors
Table 36. Entos Major Business
Table 37. Entos AI-driven Drug Discovery Product and Services
Table 38. Entos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Entos Recent Developments/Updates
Table 40. Entos Competitive Strengths & Weaknesses
Table 41. Selvita Basic Information, Area Served and Competitors
Table 42. Selvita Major Business
Table 43. Selvita AI-driven Drug Discovery Product and Services
Table 44. Selvita AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Selvita Recent Developments/Updates
Table 46. Selvita Competitive Strengths & Weaknesses
Table 47. Benevolent Basic Information, Area Served and Competitors
Table 48. Benevolent Major Business
Table 49. Benevolent AI-driven Drug Discovery Product and Services
Table 50. Benevolent AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Benevolent Recent Developments/Updates
Table 52. Benevolent Competitive Strengths & Weaknesses
Table 53. Exscientia Basic Information, Area Served and Competitors
Table 54. Exscientia Major Business
Table 55. Exscientia AI-driven Drug Discovery Product and Services
Table 56. Exscientia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Exscientia Recent Developments/Updates
Table 58. Exscientia Competitive Strengths & Weaknesses
Table 59. Euretos Basic Information, Area Served and Competitors
Table 60. Euretos Major Business
Table 61. Euretos AI-driven Drug Discovery Product and Services
Table 62. Euretos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Euretos Recent Developments/Updates
Table 64. Euretos Competitive Strengths & Weaknesses
Table 65. Illumina with AstraZeneca Basic Information, Area Served and Competitors
Table 66. Illumina with AstraZeneca Major Business
Table 67. Illumina with AstraZeneca AI-driven Drug Discovery Product and Services
Table 68. Illumina with AstraZeneca AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Illumina with AstraZeneca Recent Developments/Updates
Table 70. Illumina with AstraZeneca Competitive Strengths & Weaknesses
Table 71. Novo Nordisk with Microsoft Basic Information, Area Served and Competitors
Table 72. Novo Nordisk with Microsoft Major Business
Table 73. Novo Nordisk with Microsoft AI-driven Drug Discovery Product and Services
Table 74. Novo Nordisk with Microsoft AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Novo Nordisk with Microsoft Recent Developments/Updates
Table 76. Novo Nordisk with Microsoft Competitive Strengths & Weaknesses
Table 77. Iktos Basic Information, Area Served and Competitors
Table 78. Iktos Major Business
Table 79. Iktos AI-driven Drug Discovery Product and Services
Table 80. Iktos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Iktos Recent Developments/Updates
Table 82. Iktos Competitive Strengths & Weaknesses
Table 83. Aqemia Basic Information, Area Served and Competitors
Table 84. Aqemia Major Business
Table 85. Aqemia AI-driven Drug Discovery Product and Services
Table 86. Aqemia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Aqemia Recent Developments/Updates
Table 88. Aqemia Competitive Strengths & Weaknesses
Table 89. Zephyr AI Basic Information, Area Served and Competitors
Table 90. Zephyr AI Major Business
Table 91. Zephyr AI AI-driven Drug Discovery Product and Services
Table 92. Zephyr AI AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Zephyr AI Recent Developments/Updates
Table 94. Zephyr AI Competitive Strengths & Weaknesses
Table 95. Cyclicarx Basic Information, Area Served and Competitors
Table 96. Cyclicarx Major Business
Table 97. Cyclicarx AI-driven Drug Discovery Product and Services
Table 98. Cyclicarx AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Cyclicarx Recent Developments/Updates
Table 100. Cyclicarx Competitive Strengths & Weaknesses
Table 101. Eli Lilly Basic Information, Area Served and Competitors
Table 102. Eli Lilly Major Business
Table 103. Eli Lilly AI-driven Drug Discovery Product and Services
Table 104. Eli Lilly AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Eli Lilly Recent Developments/Updates
Table 106. Eli Lilly Competitive Strengths & Weaknesses
Table 107. Terray Therapeutics Basic Information, Area Served and Competitors
Table 108. Terray Therapeutics Major Business
Table 109. Terray Therapeutics AI-driven Drug Discovery Product and Services
Table 110. Terray Therapeutics AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Terray Therapeutics Recent Developments/Updates
Table 112. Terray Therapeutics Competitive Strengths & Weaknesses
Table 113. Ardigen Basic Information, Area Served and Competitors
Table 114. Ardigen Major Business
Table 115. Ardigen AI-driven Drug Discovery Product and Services
Table 116. Ardigen AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Ardigen Recent Developments/Updates
Table 118. Ardigen Competitive Strengths & Weaknesses
Table 119. ReviveMed Basic Information, Area Served and Competitors
Table 120. ReviveMed Major Business
Table 121. ReviveMed AI-driven Drug Discovery Product and Services
Table 122. ReviveMed AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. ReviveMed Recent Developments/Updates
Table 124. ReviveMed Competitive Strengths & Weaknesses
Table 125. Insilico Medicine Basic Information, Area Served and Competitors
Table 126. Insilico Medicine Major Business
Table 127. Insilico Medicine AI-driven Drug Discovery Product and Services
Table 128. Insilico Medicine AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Insilico Medicine Recent Developments/Updates
Table 130. Insilico Medicine Competitive Strengths & Weaknesses
Table 131. XtalPi Basic Information, Area Served and Competitors
Table 132. XtalPi Major Business
Table 133. XtalPi AI-driven Drug Discovery Product and Services
Table 134. XtalPi AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. XtalPi Recent Developments/Updates
Table 136. XtalPi Competitive Strengths & Weaknesses
Table 137. MindRank Basic Information, Area Served and Competitors
Table 138. MindRank Major Business
Table 139. MindRank AI-driven Drug Discovery Product and Services
Table 140. MindRank AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. MindRank Recent Developments/Updates
Table 142. DP Technology Basic Information, Area Served and Competitors
Table 143. DP Technology Major Business
Table 144. DP Technology AI-driven Drug Discovery Product and Services
Table 145. DP Technology AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 146. Global Key Players of AI-driven Drug Discovery Upstream (Raw Materials)
Table 147. AI-driven Drug Discovery Typical Customers
List of Figure
Figure 1. AI-driven Drug Discovery Picture
Figure 2. World AI-driven Drug Discovery Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World AI-driven Drug Discovery Total Market Size (2018-2029) & (USD Million)
Figure 4. World AI-driven Drug Discovery Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World AI-driven Drug Discovery Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company AI-driven Drug Discovery Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company AI-driven Drug Discovery Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company AI-driven Drug Discovery Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company AI-driven Drug Discovery Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company AI-driven Drug Discovery Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company AI-driven Drug Discovery Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company AI-driven Drug Discovery Revenue (2018-2029) & (USD Million)
Figure 13. AI-driven Drug Discovery Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 16. World AI-driven Drug Discovery Consumption Value Market Share by Region (2018-2029)
Figure 17. United States AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 18. China AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 23. India AI-driven Drug Discovery Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of AI-driven Drug Discovery by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI-driven Drug Discovery Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI-driven Drug Discovery Markets in 2022
Figure 27. United States VS China: AI-driven Drug Discovery Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: AI-driven Drug Discovery Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World AI-driven Drug Discovery Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World AI-driven Drug Discovery Market Size Market Share by Type in 2022
Figure 31. Small Molecule Drug
Figure 32. Biological Modeling
Figure 33. Structural Biology
Figure 34. Others
Figure 35. World AI-driven Drug Discovery Market Size Market Share by Type (2018-2029)
Figure 36. World AI-driven Drug Discovery Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World AI-driven Drug Discovery Market Size Market Share by Application in 2022
Figure 38. Pharmaceutical and Biotechnology Companies
Figure 39. Research Laboratories
Figure 40. AI-driven Drug Discovery Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
